Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab Across Various Solid Tumors
Published: June 2nd 2023 | Updated: September 17th 2024
ASCO Presentation Provides Real World Evidence of Brexu-cel’s Efficacy in R/R B-ALL
Published: September 15th 2024 | Updated: September 17th 2024
Atezolizumab After Vemurafenib and Cobimetinib Shows Trend Toward Better OS in Melanoma
Published: September 15th 2024 | Updated: September 17th 2024
10-Year Data From CheckMate 067 Confirms Survival Advantage of Nivolumab in Advanced Melanoma
Published: September 15th 2024 | Updated: September 17th 2024
Adagrasib Outperforms Docetaxel for Pretreated KRAS G12C-Mutant Non-Small Cell Lung Cancer
Published: September 14th 2024 | Updated: September 17th 2024
Preoperative Endocrine Therapy and Reduced Chemotherapy Yield Exceptional Outcomes in Hormone Receptor-Positive, HER2-Positive Breast Cancer